Exogenous alpha-1-acid glycoprotein protects against renal ischemia-reperfusion injury by inhibition of inflammation and apoptosis

Transplantation

Volumn 78, Issue 8, 2004, Pages 1116-1124

  De Vries, Bart ^a   Walter, Sarah J ^a   Wolfs, Tim G A M ^a   Hochepied, Tino ^b   Räbinä, Jarkko ^c   Heeringa, Peter ^d   Parkkinen, Jaakko ^c   Libert, Claude ^b   Buurman, Wim A ^a,e  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c FINNISH RED CROSS BLOOD SERVICE   (Finland)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

AGP; Apoptosis; Inflammation; Ischemia reperfusion; Neutrophil

Indexed keywords

ACUTE PHASE PROTEIN; APOPTOSIS INHIBITOR; COMPLEMENT COMPONENT C3; DNA; FUCOSE; MYELOPEROXIDASE; OROSOMUCOID;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL INFILTRATION; CELL INTERACTION; CELL PROTECTION; CELL STRUCTURE; COMPLEMENT SYSTEM; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE OVEREXPRESSION; GRAFT FAILURE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INHIBITION KINETICS; KIDNEY INJURY; KIDNEY TRANSPLANTATION; KIDNEY TUBULE EPITHELIUM; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; REPERFUSION INJURY; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; CYTOSKELETON; DOSE-RESPONSE RELATIONSHIP, DRUG; FUCOSE; HUMANS; INFLAMMATION; MICE; MICE, TRANSGENIC; OROSOMUCOID; RATS; RENAL CIRCULATION; REPERFUSION INJURY;

EID: 7044260438     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000138096.14126.CA     Document Type: Article

References (36)

1. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med 1996; 334(22): 1448.
2. Daemen MA, Heemskerk VH, van't Veer C, et al. Functional protection by acute phase proteins alpha(1)-acid glycoprotein and alpha(1)-antitrypsin against ischemia/reperfusion injury by preventing apoptosis and inflammation. Circulation 2000; 102(12): 1420.
3. Van Molle W, Denecker G, Rodriguez I, et al. Activation of caspases in lethal experimental hepatitis and prevention by acute phase proteins. J Immunol 1999; 163(10): 5235.
4. Muchitsch EM, Auer W, Pichler L. Effects of alpha 1-acid glycoprotein in different rodent models of shock. Fundam Clin Pharmacol 1998; 12(2): 173.
5. Libert C, Brouckaert P, Fiers W. Protection by alpha 1-acid glycoprotein against tumor necrosis factor-induced lethality. J Exp Med 1994; 180(4): 1571.
6. De Graaf TW, Van der Stelt ME, Anbergen MG, et al. Inflammation-induced expression of sialyl Lewis X-containing glycan structures on alpha 1-acid glycoprotein (orosomucoid) in human sera. J Exp Med 1993; 177(3): 657.
7. Williams JP, Weiser MR, Pechet TT, et al. alpha 1-Acid glycoprotein reduces local and remote injuries after intestinal ischemia in the rat. Am J Physiol 1997; 273: G1031.
8. Hochepied T, Berger FG, Baumann H, et al. alpha(1)-Acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties. Cytokine Growth Factor Rev 2003; 14(1): 25.
9. Fournier T, Medjoubi NN, Porquet D. Alpha-1-acid glycoprotein. Biochim Biophys Acta 2000; 1482: 157.
10. Vasson MP, Roch-Arveiller M, Couderc R, et al. Effects of alpha-1 acid glycoprotein on human polymorphonuclear neutrophils: influence of glycan microheterogeneity. Clin Chim Acta 1994; 224(1): 65.
11. Libert C, Hochepied T, Berger FG, et al. High-level constitutive expression of alpha 1-acid glycoprotein and lack of protection against tumor necrosis factor-induced lethal shock in transgenic mice. Transgenic Res 1998; 7(6): 429.
12. Hao YL, Wickerhauser M. Development of large-scale fractionation methods. IV. A simple method for the large-scale preparation of alpha1-acid glycoprotein. Biochim Biophys Acta 1973; 322(1): 99.
13. De Vries B, Matthijsen RA, Wolfs TG, et al. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation. Transplantation 2003; 75(3): 375.
14. Van Dielen FM, van't Veer C, Schols AM, et al. Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals. Int J Obes Relat Metab Disord 2001; 25(12): 1759.
15. De Vries B, Matthijsen RA, Van Bijnen AA, et al. Lysophosphatidic Acid prevents renal ischemia-reperfusion injury by inhibition of apoptosis and complement activation. Am J Pathol 2003; 163(1): 47.
16. Xiao H, Heeringa P, Hu P, et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 2002; 110(7): 955.
17. Hochepied T, Van Molle W, Berger FG, et al. Involvement of the acute phase protein alpha 1-acid glycoprotein in nonspecific resistance to a lethal gram-negative infection. J Biol Chem 2000; 275(20): 14903.
18. De Vries B, Kohl J, Leclercq WK, et al. Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils. J Immunol 2003; 170(7): 3883.
19. Daemen MA, van't Veer C, Denecker G, et al. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest 1999; 104(5): 541.
20. White SR, Williams P, Wojcik KR, et al. Initiation of apoptosis by actin cytoskeletal derangement in human airway epithelial cells. Am J Respir Cell Mol Biol 2001; 24(3): 282.
21. Van de Water B, Kruidering M, Nagelkerke JF. F-actin disorganization in apoptotic cell death of cultured rat renal proximal tubular cells. Am J Physiol 1996; 270: F593.
22. van de Water B, Nagelkerke JF, Stevens JL. Dephosphorylation of focal adhesion kinase (FAK) and loss of focal contacts precede caspase-mediated cleavage of FAK during apoptosis in renal epithelial cells. J Biol Chem 1999; 274(19): 13328.
23. Bergin E, Levine JS, Koh JS, et al. Mouse proximal tubular cell-cell adhesion inhibits apoptosis by a cadherin-dependent mechanism. Am J Physiol 2000; 278(5): F758.
24. Israili ZH, Dayton PG. Human alpha-1-glycoprotein and its interactions with drugs. Drug Metab Rev 2001; 33(2): 161.
25. Moore DF, Rosenfeld MR, Gribbon PM, et al. Alpha-1-acid (AAG, orosomucoid) glycoprotein: interaction with bacterial lipopolysaccharide and protection from sepsis. Inflammation 1997; 21(1): 69.
26. Haraldsson BS, Johnsson EK, Rippe B. Glomerular permselectivity is dependent on adequate serum concentrations of orosomucoid. Kidney Int 1992; 41(2): 310.
27. Johnsson E, Haraldsson B. Addition of purified orosomucoid preserves the glomerular permeability for albumin in isolated perfused rat kidneys. Acta Physiol Scand 1993; 147(1): 1.
28. Hillegass LM, Griswold DE, Brickson B, et al. Assessment of myeloperoxidase activity in whole rat kidney. J Pharmacol Methods 1990; 24(4): 285.
29. Laight DW, Lad N, Woodward B, et al. Assessment of myeloperoxidase activity in renal tissue after ischemia/reperfusion. Eur J Pharmacol 1994; 292(1): 81.
30. Van Molle W, Libert C, Fiers W, et al. Alpha 1-acid glycoprotein and alpha 1-antitrypsin inhibit TNF-induced but not anti-Fas-induced apoptosis of hepatocytes in mice. J Immunol 1997; 159(7): 3555.
31. Sorensson J, Ohlson M, Bjornson A, et al. Orosomucoid has a cAMP-dependent effect on human endothelial cells and inhibits the action of histamine. Am J Physiol 2000; 278(5): H1725.
32. Adamson RH, Liu B, Fry GN, et al. Microvascular permeability and number of tight junctions are modulated by cAMP. Am J Physiol 1998; 274: H1885.
33. Friedman GB, Taylor CT, Parkos CA, et al. Epithelial permeability induced by neutrophil transmigration is potentiated by hypoxia: role of intracellular cAMP. J Cell Physiol 1998; 176(1): 76.
34. Nakamura A, Imaizumi A, Yanagawa Y, et al. Beta2-adrenoceptor activation inhibits Shiga toxin2-induced apoptosis of renal tubular epithelial cells. Biochem Pharmacol 2003; 66(2): 343.
35. Riera M, Torras J, Cruzado JM, et al. The enhancement of endogenous cAMP with pituitary adenylate cyclase-activating polypeptide protects rat kidney against ischemia through the modulation of inflammatory response. Transplantation 2001; 72(7): 1217.
36. Keyler DE, Pentel PR, Haughey DB. Pharmacokinetics and toxicity of high-dose human alpha 1-acid glycoprotein infusion in the rat. J Pharm Sci 1987; 76(2): 101.